Boston Scientific continues shopping spree with LumenR Tissue Retractor System acquisition: 4 things to know

Marlborough, Mass.-based Boston Scientific officially acquired the LumenR Tissue Retractor System from Newark, Calif.-based LumenR.

Here's what you need to know.

1. The LumenR is under development. It's designed to help with endoscopic resections of lesions in the colon, esophagus or stomach.

The system will allow for enhanced visualization of lesions while creating a stable work environment to support tissue retraction and resection.

2. Senior Vice President and Endoscopy President Art Butcher said the company is excited over the potential the system shows saying, "By bringing this innovative technology forward, we have an opportunity for more physicians to treat patients successfully through less invasive endoscopic procedures."

3. Boston Scientific plans to integrate the LumenR into its endoscopy development program. It'll continue to develop and evaluate the tool before it brings the system to market.

4. The acquisition price was not disclosed, but a release states "the acquisition of LumenR is immaterial to earnings per share in 2016 and 2017.

More articles on gastroenterology/endoscopy:
Data on chronic liver disease treatment to be presented at annual AASLD meeting: 3 highlights
GI leader to know: Dr. Paul Anderson of the Oregon Clinic
Women's cancer deaths to increase by 60% through 2030: 5 colorectal cancer findings 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months